See more : Demae-Can Co.,Ltd (YUMSF) Income Statement Analysis – Financial Results
Complete financial analysis of DocGo Inc. (DCGO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DocGo Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Alchemy Creative, Inc. (ALMY) Income Statement Analysis – Financial Results
- Pure Storage, Inc. (PSTG) Income Statement Analysis – Financial Results
- GHL Systems Berhad (0021.KL) Income Statement Analysis – Financial Results
- Sahamit Machinery Public Company Limited (SMIT.BK) Income Statement Analysis – Financial Results
- Suven Pharmaceuticals Limited (SUVENPHAR.BO) Income Statement Analysis – Financial Results
DocGo Inc. (DCGO)
About DocGo Inc.
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 624.29M | 440.52M | 318.72M | 94.09M | 48.30M |
| Cost of Revenue | 428.91M | 285.79M | 208.97M | 62.74M | 35.11M |
| Gross Profit | 195.38M | 154.72M | 109.75M | 31.35M | 13.19M |
| Gross Profit Ratio | 31.30% | 35.12% | 34.43% | 33.32% | 27.31% |
| Research & Development | 10.86M | 5.38M | 3.32M | 1.19M | 1.22M |
| General & Administrative | 150.24M | 112.18M | 78.80M | 38.66M | 27.18M |
| Selling & Marketing | 2.80M | 4.76M | 4.76M | 746.24K | 1.37M |
| SG&A | 153.04M | 116.94M | 83.56M | 39.41M | 28.55M |
| Other Expenses | 0.00 | 10.57M | 7.51M | 5.51M | 4.18M |
| Operating Expenses | 180.33M | 132.89M | 94.39M | 46.10M | 33.95M |
| Cost & Expenses | 609.23M | 418.68M | 303.36M | 108.85M | 69.06M |
| Interest Income | 1.68M | 762.69K | 763.03K | 204.63K | 545.87K |
| Interest Expense | 0.00 | 762.69K | 763.03K | 204.63K | 0.00 |
| Depreciation & Amortization | 16.43M | 10.57M | 7.51M | 5.51M | 4.18M |
| EBITDA | 31.75M | 32.40M | 28.07M | -9.25M | -16.58M |
| EBITDA Ratio | 5.09% | 7.77% | 5.51% | -10.18% | -34.57% |
| Operating Income | 15.05M | 21.83M | 10.49M | -14.76M | -20.76M |
| Operating Income Ratio | 2.41% | 4.96% | 3.29% | -15.68% | -42.99% |
| Total Other Income/Expenses | 1.24M | 950.26K | 4.44M | 125.91K | -428.28K |
| Income Before Tax | 16.29M | 22.78M | 19.80M | -14.63M | -21.19M |
| Income Before Tax Ratio | 2.61% | 5.17% | 6.21% | -15.55% | -43.87% |
| Income Tax Expense | 6.24M | -7.96M | 615.70K | 167.44K | 47.03K |
| Net Income | 6.86M | 34.58M | 23.74M | -14.80M | -21.24M |
| Net Income Ratio | 1.10% | 7.85% | 7.45% | -15.73% | -43.97% |
| EPS | 0.07 | 0.34 | 0.30 | -0.25 | -0.21 |
| EPS Diluted | 0.06 | 0.34 | 0.25 | -0.25 | -0.21 |
| Weighted Avg Shares Out | 103.51M | 101.23M | 80.29M | 58.37M | 100.22M |
| Weighted Avg Shares Out (Dil) | 105.62M | 102.98M | 94.86M | 58.37M | 100.22M |
DocGo Named Finalist for National Compliance Awards
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that it has been selected as a finalist for two separate independent awards for its compliance and risk programs. The...
DocGo Expands Care Gap Closure Program to Enhance Healthcare Access for Hundreds of Thousands of Medicaid Recipients in California
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the expansion of a program to enhance healthcare access for California Medi-Cal enrollees/patients/members. The program aims to re-engage patients with...
DocGo Announces Participation at Four Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September: Midwest Ideas Conference (August 28th – 29th) Norm Rosenberg,...
DocGo Inc. (DCGO) Q2 Earnings and Revenues Miss Estimates
DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.02 per share a year ago.
DocGo Inc. (DCGO) Q2 2024 Earnings Call Transcript
DocGo Inc. (NASDAQ:DCGO ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Mike Cole – Vice President, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Sarah...
DocGo Secures $4 Million Contract Extension to Continue Vital 911 Basic Life Support Services for Atlantic City, New Jersey
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that Exceptional Medical Transportation, a DocGo subsidiary with a specialty in Critical Care Transportation, has been awarded a one-year, $4...
DocGo Inc Investigated By The Schall Law Firm Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations...
DocGo Inc Investigated By The Schall Law Firm Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations...
DocGo Inc Investigated By The Schall Law Firm Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations...
DocGo Inc Investigated By The Schall Law Firm Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations...
Source: https://incomestatements.info
Category: Stock Reports